Arcadia Bio appoints Matthew Plavan as CFO
Mr. Plavan brings nearly 30 years of financial and executive leadership experience to Arcadia in the areas of business operations, fiscal management and strategy, commercial partnering, M&A and integration activities, and public and private equity fundraising.
Most recently, Mr. Plavan served in multiple executive capacities, including CFO, COO and CEO with Cesca Therapeutics, Inc., a company engaged in research, development and commercialization of autologous cell-based therapeutics.
Prior to Cesca, he served as CFO with venture and private equity-backed technology companies, including Strion Air, Inc. and Reason, Inc.
He also held executive finance positions with McKesson Corporation and audit and advisory management positions with Ernst & Young.
Mr. Plavan is a certified public accountant and earned a B.A. in business economics from the University of California, Santa Barbara.
Steve Brandwein, Arcadia’s VP of finance and administration, who has been serving as interim CFO, will be retiring from the company as soon as an orderly transition is complete. ■
LATEST MOVES FROM California
- Qualcomm appoints James Thompson as new CTO
- Sunworks names Charles Cargile as new CEO
- ChromaDex appoints Steven Rubin to board
- Impax Laboratories appoints Paul M. Bisaro as CEO
- Retrophin names John A. Orwin to board
More inside POST